((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(di(naphthalen-1-yl)methanol), 95% 99%ee, 100g

Dichlorodiphenylsilane>98.0%(GC)100g

2-Bromo-3,6-difluoroanisole, 97.0%, 250mg

tBuXPhos Pd G3, >98.0%, 100g

(3aR,6aR)-rel-Hexahydropyrrolo[3,4-b]pyrrol-6(2H)-one, 250mg

6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one compound with 2-aminoethanol (1:1), 95.0%, 100g

5-Amino-3-bromobenzonitrile, 95.0%, 250mg

Natronlauge 40 %, reinst, 2.5 l, kunststoffverpackung.

(R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one (Ibrutinib Impurity), 97%, 50mg

1-Chloro-4-fluorobenzene>95.0%(GC)25g

2-Cyano-N-[2-(trifluoromethyl)phenyl]acetamide, 250mg

N,3-dimethyl-2-butanamine hydrochloride, 95.0%, 25g

(5-Bromo-4-chloro-2-fluorophenyl)methanol, 98%, 2g